All In Biotech

Drug Trial Radar · NCT06570291

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis

A Multicenter, Randomized, Double-blind, Controlled Phase III Trial of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells (AlloJoin®) Therapy for Knee Osteoarthritis.

Last checked: Nov 19, 2026Latest source record: Jul 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 520 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

520

Planned (sponsor's estimate)

Start

Feb 28, 2025

Primary completion

Dec 2026

Study completion Dec 2028

Sponsor

Sponsor type
Industry
First posted
Aug 26, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Evaluate the efficacy and safety of Allogenic Adipose Tissue-Derived Mesenchymal Stem Cells Therapy

Conditions

  • Knee Osteoarthritis

Interventions

  • Mesenchymal Stem CellsDrug

    Allogenic adipose tissue-derived mesenchymal stem cells administrated for intra- articular use

  • Sodium Hyaluronate InjectionDrug

    Sodium Hyaluronate administrated for intra-articular use

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. WOMAC scoreTime frame: 48 weeks
  2. MRI quantitative analysis of articular cartilageTime frame: 24 weeks

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, China · Not yet recruiting

  • RenJi Hospital

    Shanghai, China, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.